Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
04/2003
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/29/2003US6555537 Piperazine derivatives and their use as anti-inflammatory agents
04/24/2003WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078237 Treatment of a central nervous system disorders
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303479A2 7-, 8- and 9-substituted tetracycline compounds
04/23/2003EP1007032B1 4-cyano-4-deformylsordaricin derivatives
04/23/2003EP0906322B1 Novel chiral bisphosphines
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003CN1106395C Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
04/22/2003US6552195 Quinoxaline-containing AB2 monomers for hyperbranched aromatic polyamides
04/22/2003US6552042 Anticoagulants
04/22/2003US6552025 Diimino-piperazine derivatives for use as modulators of cell regulation
04/22/2003US6552023 Aralkyl substituted piperazine compounds
04/22/2003US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels
04/17/2003WO2003031406A2 Kinase inhibitor scaffolds and methods for their preparation
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003030886A2 Allylamides useful in the treatment of alzheimer's disease
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073832 Novel aminophenyl ketone derivatives
04/17/2003US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073681 Mammal cellular receptors; therapy for psychological disorders, analgesics, hypotensive agents
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003CA2463563A1 Kinase inhibitor scaffolds and methods for their preparation
04/17/2003CA2462875A1 Allylamides useful in the treatment of alzheimer's disease
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1301210A2 Compositions containing therapeutically active components having enhanced solubility
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/15/2003US6548671 Quinoxalinyl amide derivatives
04/15/2003US6548670 Reacting chloro(or bromo)alkylquinoxaline with nucleophilic compound in presence of phase transfer catalyst to make hydroxyalkylquinoxaline; debromination, dechlorination, hydroxylation
04/15/2003US6548668 Stabilizer for proteins
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/10/2003WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists
04/10/2003WO2003029232A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2002089738A3 Proteomimetic compounds and methods
04/10/2003US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors
04/09/2003EP1299401A1 Chiral ligands for asymmetric catalysis
04/09/2003CN1408711A Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method
04/09/2003CN1408710A Method for synthesizing cis-2,6-dimethyl piperazine
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105111C Pyrazine compounds
04/08/2003US6545038 Heterocyclic metalloprotease inhibitors
04/08/2003US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein
04/08/2003US6544298 Dyeing human hair using coupler
04/08/2003CA2123548C Piperazine derivatives
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027061A2 Muscarinic agonists
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030064994 Substituted alkyl piperazine derivatives
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104423C Preparation of N-tert-butyl-2-piperazine carboxyl amides
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541633 2,3-bis(3-amino-4-hydroxy or 4-mercapto or 4-NH2.HCLphenyl)quinoxaline-6- carboxylic acid dihydrochloride monomer, which self-polymerizes to form hyperbranched polybenzoxazoles, polybenzothizoles etc.
04/01/2003US6541476 Piperazine derivatives and their use as anti-inflammatory agents
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/2003
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024918A1 Intermediate compounds for the preparation of mirtazapine and the production methods thereof
03/27/2003WO2003024441A1 Novel use of tricyclic compound
03/27/2003WO2003024401A2 Piperizinones as modulators of chemokine receptor activity
03/27/2003US20030060629 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060473 Piperazine compounds as inhibitors of MMP or TNF
03/27/2003US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003CA2460571A1 Intermediate compounds for the preparation of mirtazapine and obtention methods thereof
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/26/2003EP1295882A1 Process for the preparation of a piperazine derivative
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295868A1 Amide compounds and use thereof